Skip to main navigation Skip to search Skip to main content

A Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Cavrotolimod Alone and in Combinations in Subjects with Chronic Hepatitis B Infection

Project: Research

Project Details

StatusFinished
Effective start/end date17/08/2417/08/26

Keywords

  • clinical trial
  • Hepatitis B
  • Cavrotolimod

Clinical Trial Phase

  • Phase I
  • Phase II